GSK3B and fatty liver disease: Moreover, when inhibiting Gsk3b activity, diet-induced obese mice significantly improved obesity symptoms, such as body weight gain, increased adiposity, dyslipidemia, and hepatic steatosis, due to the marked reduction of whole-body lipid content [43].